Gene content    
NFKB2 ( by HUGO)
Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer...
Oncogene
Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 2 (P49/P100)
LYT10
Lymphocyte Translocation Chromosome 10 Protein
Oncogene Lyt-10
H2TF1
DNA-Binding Factor KBF2
CVID10
LYT-10
NF-kB2
NFKB
P52/P100 Subunit
Nuclear Factor Kappa-B
Subunit 2
Nuclear Factor NF-Kappa-B P100 Subunit
Nuclear Factor Of Kappa Light Chain Gene Enhancer In B Cells 2
p105
p52
Transcription Factor NFKB2
Lyt10
Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 2
NCBI: 10q24    Ensembl: 10q24.32
NFKB2_HUMANSize: 900 amino acidsMass: 96749 Da

  • Subunit: Component of the NF-kappa-B RelB-p52 complex. Homodimer; component of the NF-kappa-B p52-p52 complex. Component of the NF-kappa-B p65-p52 complex. Component of the NF-kappa-B p52-c-Rel complex. NFKB2/p52 interacts with NFKBIE. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Directly interacts with MEN1 Sequence caution: Sequence=CAA43715.1; Type=Frameshift; Positions=456, 458, 470, 900;
  • Function:
    UniProtKB/Swiss-Prot Summary: NFKB2_HUMAN, Q00653 Function: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65
  • Similarity:
    Contains 7 ANK repeats
                          
    Contains 1 death domain
                          
    Contains 1 RHD (Rel-like) domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000451NF_Rel_DorNF-kappa-B/Rel/dorsalFamily
    IPR000488Death_domainDeathDomain
    IPR002110Ankyrin_rptAnkyrinRepeat
    IPR002909IPTCell surface receptor IPT/TIGDomain
    IPR008967p53-like_TF_DNA-bdp53-like transcription factor, DNA-bindingDomain
    IPR011029DEATH-like_domDEATH-likeDomain
    IPR011539RHDRel homologyDomain
    BlocksIPB000451NF-kappa-B/Rel/dorsal familyNF-kappa-B/Rel/dorsal family
    IPB000488Death domainDeath domain
    IPB002110Ankyrin repeat signatureAnkyrin repeat signature
    IPB002909Cell surface receptor IPT/TIGCell surface receptor IPT/TIG

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process regulation of transcription, DNA-templated IDA GOA 8360178
    Cellular Component Bcl3/NF-kappaB2 complex IDA GOA 9407099
    Molecular Function protein binding IPI GOA 11239468
    transcription coactivator activity TAS GOA 1876189

    Disorder & Mutation    
    Source Disease
    Genatlaslymphoma,B cell,non Hodgkin,associated with breakpoint in t(10;14)(q24;q32) translocation
    SWISS-PROTNote=In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions
    SWISS-PROTNote=A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which codes for a truncated 80 kDa protein (p80HT)
    SWISS-PROTNote=A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant

    NFKB2 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene